Veracyte, Inc.(VCYT)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
VCYT | 3.60 B | 31.99x | 15.50% | 20.37% | $1.40 | 8.77% | 0.03x | 0.00% | $60.91 | $29.46 |
TMO | 254.15 B | 37.00x | 10.50% | 15.04% | $18.58 | 13.52% | 0.81x | 0.26% | $704.00 | $434.50 |
NTRA | 58.51 B | - | 37.70% | -7.11% | -$1.35 | -12.54% | 0.13x | 0.00% | $437.41 | $181.00 |
ILMN | 40.46 B | 49.99x | 9.40% | 18.34% | $5.36 | 32.34% | 0.89x | 0.00% | $309.35 | $94.00 |
GH | 21.82 B | - | 44.30% | -38.33% | -$3.50 | - | - | 0.00% | $191.05 | $65.96 |
Peer Valuation & Performance Analysis
Peer group analysis for Veracyte, Inc. (VCYT) compared to its primary competitors (including TMO, NTRA, ILMN) reveals distinct metrics. VCYT trades at a valuation premium compared to its competitors, with a P/E ratio of 32.0x versus the peer average of -65.0x (representing a -149% premium). This indicates that the market expects superior growth or commands a quality premium for VCYT. In terms of growth, VCYT's revenue growth of 15.5% lags behind the peer average of 25.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 20.4% compared to the peer average of -3.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• VCYT ranks #1 in P/E ratio, #3 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $43.91 | $45.17 | $43.47 | $44.79 | 1,136,404 | +2.26% |
| 2026-10-19 | $43.70 | $45.01 | $43.45 | $43.80 | 725,400 | +1.58% |
| 2026-10-16 | $45.00 | $45.75 | $42.83 | $43.12 | 2,063,200 | -2.86% |
| 2026-10-15 | $43.36 | $45.58 | $42.70 | $44.39 | 1,227,200 | +2.02% |
| 2026-10-14 | $42.37 | $43.99 | $42.20 | $43.51 | 935,300 | +0.93% |
| 2026-10-13 | $43.67 | $44.29 | $43.03 | $43.11 | 760,400 | -2.07% |
| 2026-10-12 | $45.18 | $45.22 | $43.29 | $44.02 | 1,151,600 | -2.68% |
| 2026-10-09 | $43.70 | $46.17 | $43.50 | $45.23 | 966,500 | +3.74% |
| 2026-10-08 | $42.50 | $43.67 | $41.22 | $43.60 | 1,221,600 | +1.02% |
| 2026-10-07 | $44.04 | $44.21 | $42.34 | $43.16 | 1,213,600 | -3.34% |
| 2026-10-06 | $48.00 | $48.84 | $44.09 | $44.65 | 1,730,800 | -6.34% |
| 2026-10-05 | $45.75 | $47.78 | $45.00 | $47.67 | 1,289,100 | +4.06% |
| 2026-10-02 | $44.94 | $46.09 | $44.41 | $45.81 | 1,041,700 | +3.67% |
| 2026-10-01 | $45.66 | $47.14 | $44.18 | $44.19 | 1,426,700 | -4.02% |
| 2026-09-30 | $45.93 | $46.78 | $45.60 | $46.04 | 1,184,200 | -0.09% |
Explore More Analysis for VCYT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.